Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 24, 2014 - Issue 4
Submit an article Journal homepage
327
Views
10
CrossRef citations to date
0
Altmetric
Patent Evaluations

Evaluation of WO2013136076: two crystalline forms of the phosphatidylinositol 3-kinase-δ inhibitor RV-1729

Peter NormanNorman Consulting, 18 Pink Lane, Burnham, Bucks, SL1 8JW, [email protected]
, MBA PhD
Pages 471-475 | Published online: 27 Nov 2013

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Paul Glossop, Gavin Whitlock & Karl Gibson. (2015) Small-molecule anti-inflammatory drug compositions for the treatment of asthma: a patent review (2013 – 2014). Expert Opinion on Therapeutic Patents 25:7, pages 743-754.
Read now
Peter Norman. (2014) Evaluation of WO2014075392 and WO2014075393, Merck’s first PI3Kδ inhibitor filings. Expert Opinion on Therapeutic Patents 24:11, pages 1277-1282.
Read now

Articles from other publishers (8)

Jun Wei, Dongyan Gu, Leer Yuan & Rong Sheng. (2023) Advances in the Discovery of Novel Inhaled PI3Kδ Inhibitors for the Treatment of Asthma. Current Medicinal Chemistry 30:17, pages 1971-1992.
Crossref
Akira Yamasaki, Ryota Okazaki & Tomoya Harada. (2022) Neutrophils and Asthma. Diagnostics 12:5, pages 1175.
Crossref
Chiara Tarantelli, Lisa Argnani, Pier Luigi Zinzani & Francesco Bertoni. (2021) PI3Kδ Inhibitors as Immunomodulatory Agents for the Treatment of Lymphoma Patients. Cancers 13:21, pages 5535.
Crossref
Sharif Moradi, Esmaeil Jarrahi, Ali Ahmadi, Jafar Salimian, Mehrdad Karimi, Azadeh Zarei, Sadegh Azimzadeh Jamalkandi & Mostafa Ghanei. (2021) PI3K signalling in chronic obstructive pulmonary disease and opportunities for therapy . The Journal of Pathology 254:5, pages 505-518.
Crossref
Flora Pirozzi, Kai Ren, Alessandra Murabito & Alessandra Ghigo. (2019) PI3K Signaling in Chronic Obstructive Pulmonary Disease: Mechanisms, Targets, and Therapy. Current Medicinal Chemistry 26:16, pages 2791-2800.
Crossref
Matthew W. D. Perry, Raolat Abdulai, Mickael Mogemark, Jens Petersen, Matthew J. Thomas, Barbara Valastro & Annika Westin Eriksson. (2018) Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases. Journal of Medicinal Chemistry 62:10, pages 4783-4814.
Crossref
Manman Wei, Xi Zhang, Xiang Wang, Zilan Song, Jian Ding, Ling-Hua Meng & Ao Zhang. (2017) SAR study of 5-alkynyl substituted quinazolin-4(3H)-ones as phosphoinositide 3-kinase delta (PI3Kδ) inhibitors. European Journal of Medicinal Chemistry 125, pages 1156-1171.
Crossref
Manman Wei, Xiang Wang, Zilan Song, Mingkun Jiao, Jian Ding, Ling-Hua Meng & Ao Zhang. (2015) Targeting PI3Kδ: Emerging Therapy for Chronic Lymphocytic Leukemia and Beyond. Medicinal Research Reviews 35:4, pages 720-752.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.